Gene · 3832
Papers3,579
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 3,579
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Lipophilic Studies and In Silico ADME Profiling of Biologically Active 2-Aminothiazol-4(5H)-one Derivatives. | Int J Mol Sci | 2023 | 37569606 | PubTator, text mining | PubMed |
| Protective Effects of 3'-Epilutein and 3'-Oxolutein against Glutamate-Induced Neuronal Damage. | Int J Mol Sci | 2023 | 37569384 | PubTator, text mining | PubMed |
| Microcephaly and Chorioretinopathy Relevance as a Differential Diagnosis. | Diagnostics (Basel) | 2023 | 37568951 | PubTator, text mining | PubMed |
| Potential Molecular Targets in the Treatment of Patients with CNS Tumors. | Cancers (Basel) | 2023 | 37568623 | PubTator, text mining | PubMed |
| New insights into the mechanochemical coupling mechanism of kinesin-microtubule complexes from their high-resolution structures. | Biochem Soc Trans | 2023 | 37560910 | PubTator, text mining | PubMed |
| Validation of the Idylla GeneFusion assay to detect fusions and MET exon-skipping in non-small cell lung cancers. | Sci Rep | 2023 | 37558711 | PubTator, text mining | PubMed |
| Identification of distinct gene co-expression modules and specific hub genes in skin lesions of atopic dermatitis and psoriasis by WGCNA. | FEBS Open Bio | 2023 | 37548115 | PubTator, text mining | PubMed |
| Identification and validation of risk score model based on gene set activity as a diagnostic biomarker for endometriosis. | Heliyon | 2023 | 37539146 | PubTator, text mining | PubMed |
| Retracted: KIF11 Is a Promising Therapeutic Target for Thyroid Cancer Treatment. | Comput Math Methods Med | 2023 | 37538467 | PubTator, text mining | PubMed |
| System analysis identifies UBE2C as a novel oncogene target for adrenocortical carcinoma. | PLoS One | 2023 | 37535572 | PubTator, text mining | PubMed |
| Exploring genetic loci of type 2 diabetes and cancer: a review. | Endocr Oncol | 2023 | 37529774 | PubTator, text mining | PubMed |
| Phenotypic heterogeneity in human genetic diseases: ultrasensitivity-mediated threshold effects as a unifying molecular mechanism. | J Biomed Sci | 2023 | 37525275 | PubTator, text mining | PubMed |
| Matrix Metalloproteinases Inhibitors in Cancer Treatment: An Updated Review (2013-2023). | Molecules | 2023 | 37513440 | PubTator, text mining | PubMed |
| HURP localization in metaphase is the result of a multi-step process requiring its phosphorylation at Ser627 residue. | Front Cell Dev Biol | 2023 | 37484914 | PubTator, text mining | PubMed |
| Diagnostic biomarker KIF23 is associated with immune infiltration and immunotherapy response in gastric cancer. | Front Oncol | 2023 | 37483517 | PubTator, text mining | PubMed |
| Microtubule nucleation for spindle assembly: one molecule at a time. | Trends Biochem Sci | 2023 | 37482516 | PubTator, text mining | PubMed |
| Pan-Cancer Analysis Reveals CENPI as a Potential Biomarker and Therapeutic Target in Adrenocortical Carcinoma. | J Inflamm Res | 2023 | 37465344 | PubTator, text mining | PubMed |
| Overexpression of POLA2 in hepatocellular carcinoma is involved in immune infiltration and predicts a poor prognosis. | Cancer Cell Int | 2023 | 37452331 | PubTator, text mining | PubMed |
| Crosstalk between KIF1C and PRKAR1A in left atrial myxoma. | Commun Biol | 2023 | 37452081 | PubTator, text mining | PubMed |
| Proteomic Modulation in TGF-β-Treated Cholangiocytes Induced by Curcumin Nanoparticles. | Int J Mol Sci | 2023 | 37445659 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3832/papers?page=21